Literature DB >> 6381892

The beneficial effects of cyclovirobuxine D (CVBD) in coronary heart disease. A double blind analysis of 110 cases.

P Shan, R B Mao, J M Xu, J X Li.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381892

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


× No keyword cloud information.
  1 in total

1.  Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment.

Authors:  Qian Guo; Jiabin Guo; Rong Yang; Hui Peng; Jun Zhao; Li Li; Shuangqing Peng
Journal:  Oxid Med Cell Longev       Date:  2015-05-14       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.